British Isles Survey of Methotrexate Monitoring Practice During Treatment of Juvenile Idiopathic Arthritis

Seminars in Arthritis and Rheumatism

Volumn 40, Issue 4, 2011, Pages

  Hawley, Daniel P ^a   Camina, Nikki ^a   Rangaraj, Satyapal ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Cirrhosis; DMARDs; Full blood count; Juvenile idiopathic arthritis; Juvenile rheumatology; Liver enzymes; Methotrexate; Monitoring; Pediatric

Indexed keywords

ALANINE AMINOTRANSFERASE; LIVER ENZYME; METHOTREXATE;

ARTICLE; BLOOD CELL COUNT; CHILD HEALTH CARE; CONTROLLED STUDY; DRUG MONITORING; HEALTH CARE ORGANIZATION; HEALTH SURVEY; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; NAUSEA AND VOMITING; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RHEUMATOLOGY; SIDE EFFECT; UNITED KINGDOM;

EID: 78751704486     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2010.05.001     Document Type: Article

References (16)

1. Gubner R., August S., Ginsberg V. Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis. Am J Med Sci 1951, 221(2):176-182.
2. BSPAR Guidelines on methotrexate use in paediatric rheumatology Approved by the BSPAR executive committee in 2005, accessed January 2010. http://www.bspar.org.uk/pages/clinical_guidelines.asp.
3. Gutierrez-Ureña S., Molina J.F., García C.O., Cuéllar M.L., Espinoza L.R. Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis. Arthritis Rheum 1996, 39(2):272-276.
4. Lateef O., Shakoor N., Balk R.A. Methotrexate pulmonary toxicity. Exp Opin Drug Saf 2005, 4(4):723-730.
5. Roenigk H.H., Auerbach R., Maibach H.I., Weinstein G.D. Methotrexate guidelines: revised. J Am Acad Dermatol 1982, 6(2):145-155.
6. Furst D.E., Kremer J.M. Methotrexate in rheumatoid arthritis. Arthritis Rheum 1988, 31(3):305-314.
7. Kremer J.M., Kaye G.I., Kaye N.W., Ishak K.G., Axiotis C.A. Light and electron microscopic analysis of sequential liver biopsy samples from rheumatoid arthritis patients receiving long-term methotrexate therapy. Follow up over long treatment intervals and correlation with clinical and laboratory variables. Arthritis Rheum 1995, 38(9):1194-1203.
8. Kremer J.M., Furst D.E., Weinblatt M.E., Blotner S.D. Significant changes in serum AST across hepatic histological biopsy grades: prospective analysis of 3 cohorts receiving methotrexate therapy for rheumatoid arthritis. J Rheumatol 1996, 23(3):459-461.
9. Kremer J.M., Alarcón G.S., Lightfoot R.W., Willkens R.F., Furst D.E., Williams H.J., et al. Methotrexate for rheumatoid arthritis: suggested guidelines for monitoring liver toxicity. American College of Rheumatology. Arthritis Rheum 1994, 37:316-328.
10. Chakravarty K., McDonald H., Pullar T., Taggart A., Chalmers R., Oliver S., et al. BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists. Rheumatology 2008, 47(6):924-925. [Published Online First: 28 August 2006. doi:10.1093/rheumatology/ke1216a].
11. (accessed January 2010). http://www.surveymonkey.com/.
12. Chédeville G., Scuccimarri R., Duffy C.M. Survey on the use of methotrexate by pediatric rheumatologists in Canada. J Rheumatol 2007, 34(4):818-822.
13. Salliot C., van der Heijde D. Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research. Ann Rheum Dis 2009, 68(7):1100-1104. [Published Online First: 5 December 2008. doi:10.1136/ard.2008.093690].
14. Kremer J.M., Lee J.K. The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis. Arthritis Rheum 1986, 29(7):822-831.
15. Tishler M., Caspi D., Halperin Z., Baratz M., Moshkowitz M., Yaron M. A prospective analysis of liver biopsies in rheumatoid arthritis patients receiving long term methotrexate therapy. Rheumatol Int 1992, 12(1):39-41.
16. Ortiz-Alvarez O., Morishita K., Avery G., Green J., Petty R.E., Tucker L.B., et al. Guidelines for blood test monitoring of methotrexate toxicity in juvenile idiopathic arthritis. J Rheumatol 2004, 31(12):2501-2506.